Can-Fite Biopharma (CANF) has the following price history information. Looking back at CANF historical stock prices for the last five trading days, on April 29, 2024, CANF opened at $1.98, traded as high as $2.02 and as low as $1.95, and closed at $1.97. Trading volume was a total of 8.70K shares. On April 30, 2024, CANF opened at $2.00, traded as high as $2.25 and as low as $2.00, and closed at $2.07. Trading volume was a total of 45.40K shares. On May 01, 2024, CANF opened at $2.12, traded as high as $2.12 and as low as $2.00, and closed at $2.09. Trading volume was a total of 27.30K shares. On May 02, 2024, CANF opened at $2.09, traded as high as $2.21 and as low as $2.01, and closed at $2.03. Trading volume was a total of 10.90K shares. On May 03, 2024, CANF opened at $2.10, traded as high as $2.15 and as low as $2.00, and closed at $2.09. Trading volume was a total of 3.20K shares.

CANF Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Can-Fite Biopharma shares, starting with a $10,000 purchase of CANF, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	05/06/2014
End date:	05/03/2024
Start price/share:	$712.50
End price/share:	$2.09
Dividends collected/share:	$0.00
Total return:	-99.71%
Average Annual Total Return:	-44.19%
Starting investment:	$10,000.00
Ending investment:	$29.32
Years:	10.00

CANF Historical Price Range
Date	Open	High	Low	Close	Volume
04/29/2024	$1.98	$2.02	$1.95	$1.97	8.70K
04/30/2024	$2.00	$2.25	$2.00	$2.07	45.40K
05/01/2024	$2.12	$2.12	$2.00	$2.09	27.30K
05/02/2024	$2.09	$2.21	$2.01	$2.03	10.90K
05/03/2024	$2.10	$2.15	$2.00	$2.09	3.20K

About Can-Fite Biopharma

Can-Fite Biopharma is a clinical-stage biopharmaceutical company focused on developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver, inflammatory diseases, COVID-19 and erectile dysfunction. Co. also co-develops formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Co.'s platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. Co.'s pipeline of drug candidates are synthetic, agonists and allosteric modulators, or ligands or molecules that initiate molecular events when binding with target proteins, targeting the A3AR.

CANF Historical Closing Prices
Date	Close
04/29/2024	$1.97
04/30/2024	$2.07
05/01/2024	$2.09
05/02/2024	$2.03
05/03/2024	$2.09

CANF Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.